Bio Rad Laboratories Stock Total Debt
| BIO Stock | USD 285.28 5.15 1.84% |
Bio Rad Laboratories fundamentals help investors to digest information that contributes to Bio Rad's financial success or failures. It also enables traders to predict the movement of Bio Stock. The fundamental analysis module provides a way to measure Bio Rad's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio Rad stock.
As of the 24th of April 2024, Total Debt To Capitalization is likely to drop to 0.12. Bio | Total Debt |
Bio Rad Laboratories Company Total Debt Analysis
Bio Rad's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Bio Rad Total Debt | 1.41 B |
Most of Bio Rad's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio Rad Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Bio Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Bio Rad is extremely important. It helps to project a fair market value of Bio Stock properly, considering its historical fundamentals such as Total Debt. Since Bio Rad's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bio Rad's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bio Rad's interrelated accounts and indicators.
Click cells to compare fundamentals
Bio Total Debt Historical Pattern
Today, most investors in Bio Rad Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Bio Rad's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Bio Rad total debt as a starting point in their analysis.
Bio Rad Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Bio Short Long Term Debt Total
Short Long Term Debt Total |
|
Based on the latest financial disclosure, Bio Rad Laboratories has a Total Debt of 1.41 B. This is 48.9% lower than that of the Life Sciences Tools & Services sector and 19.53% lower than that of the Health Care industry. The total debt for all United States stocks is 73.56% higher than that of the company.
Bio Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio Rad's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio Rad could also be used in its relative valuation, which is a method of valuing Bio Rad by comparing valuation metrics of similar companies.Bio Rad is currently under evaluation in total debt category among related companies.
Bio Rad ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bio Rad's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bio Rad's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Bio Rad Institutional Holders
Institutional Holdings refers to the ownership stake in Bio Rad that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bio Rad's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bio Rad's value.| Shares | Thompson, Siegel & Walmsley Llc | 2023-12-31 | 348.5 K | Massachusetts Financial Services Company | 2023-12-31 | 322.3 K | Goldman Sachs Group Inc | 2023-12-31 | 288.7 K | Hound Partners, Llc | 2023-12-31 | 261.7 K | Northern Trust Corp | 2023-12-31 | 252.4 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 250.1 K | Westfield Capital Management Company, Lp | 2023-12-31 | 247.2 K | Parnassus Investments Llc | 2023-12-31 | 237.8 K | Norges Bank | 2023-12-31 | 226.5 K | Vanguard Group Inc | 2023-12-31 | 2.4 M | Blackrock Inc | 2023-12-31 | 1.5 M |
Bio Fundamentals
| Return On Equity | -0.0694 | ||||
| Return On Asset | 0.0177 | ||||
| Profit Margin | (0.24) % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 7.78 B | ||||
| Shares Outstanding | 23.42 M | ||||
| Shares Owned By Insiders | 15.23 % | ||||
| Shares Owned By Institutions | 81.68 % | ||||
| Number Of Shares Shorted | 564.75 K | ||||
| Price To Earning | 2.90 X | ||||
| Price To Book | 0.98 X | ||||
| Price To Sales | 3.28 X | ||||
| Revenue | 2.67 B | ||||
| Gross Profit | 1.57 B | ||||
| EBITDA | 576.2 M | ||||
| Net Income | (637.32 M) | ||||
| Cash And Equivalents | 434.21 M | ||||
| Cash Per Share | 62.03 X | ||||
| Total Debt | 1.41 B | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 5.50 X | ||||
| Book Value Per Share | 306.51 X | ||||
| Cash Flow From Operations | 374.94 M | ||||
| Short Ratio | 3.22 X | ||||
| Earnings Per Share | (21.82) X | ||||
| Price To Earnings To Growth | 1.19 X | ||||
| Target Price | 409.8 | ||||
| Number Of Employees | 8.03 K | ||||
| Beta | 0.88 | ||||
| Market Capitalization | 7.99 B | ||||
| Total Asset | 12.3 B | ||||
| Retained Earnings | 9.26 B | ||||
| Working Capital | 2.53 B | ||||
| Current Asset | 466.61 M | ||||
| Current Liabilities | 208.93 M | ||||
| Net Asset | 12.3 B |
About Bio Rad Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio Rad Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Rad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Rad Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Bio Rad Investors Sentiment
The influence of Bio Rad's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bio. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Bio Rad's public news can be used to forecast risks associated with an investment in Bio. The trend in average sentiment can be used to explain how an investor holding Bio can time the market purely based on public headlines and social activities around Bio Rad Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bio Rad's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bio Rad's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Bio Rad's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Bio Rad.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bio Rad in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bio Rad's short interest history, or implied volatility extrapolated from Bio Rad options trading.
Pair Trading with Bio Rad
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.Moving together with Bio Stock
| 0.62 | BMY | Bristol Myers Squibb Earnings Call Tomorrow | PairCorr |
| 0.61 | CRL | Charles River Labora Financial Report 9th of May 2024 | PairCorr |
Moving against Bio Stock
| 0.74 | ELYM | Eliem Therapeutics | PairCorr |
The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Bio Rad Piotroski F Score and Bio Rad Altman Z Score analysis. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Bio Stock analysis
When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.56) | Earnings Share (21.82) | Revenue Per Share 91.453 | Quarterly Revenue Growth (0.07) | Return On Assets 0.0177 |
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.